Evolent Health Inc.
EVH | NYSE
$3.69
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$3.69
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:01 PM ET
Market Data
Market Cap $415.06M
Enterprise Value $303.32M
Beta 0.84
Average Volume 2.96M
Shares Outstanding (Diluted) 112.54M
Shares Change YoY -2.88%
Institutional Ownership 99.00%
Exchange NYSE
ISIN US30050B1017
Price Performance
Price Change 1M -21.0%
Price Change 3M -23.1%
Price Change 6M 62.6%
Price Change YTD -5.1%
Price Change 1Y -57.0%
Price Change 3Y -86.1%
Price Change 5Y -85.9%
1M CAGR (ann.) 2.8%
1Y CAGR (ann.) -56.8%
5Y CAGR (ann.) -31.9%
All-Time CAGR -13.4%
Valuation
PE Ratio -0.82
Forward PE 9.38
PEG Ratio 0.00
Forward PEG -0.01
PS Ratio 0.20
Forward PS 0.10
PB Ratio 1.08
P/FCF Ratio 24.49
P/Adj. FCF Ratio -19.59
P/OCF Ratio 7.85
EV/Sales 0.14
EV/EBIT -0.70
EV/EBITDA -0.96
EV/FCF 17.90
Earnings Yield -121.7%
FCF Yield 4.1%
Adj. FCF Yield -5.1%
Financial Health
Net Cash $111.74M
Total Debt $3.97M
Cash & Short-Term Investments $115.7M
Total Assets $1.97B
Current Ratio 1.24
Quick Ratio 1.24
Debt / Equity Ratio 2.53
Debt / EBITDA -0.01
Debt / FCF 0.23
OCF / Debt 13.44
Interest Coverage -0.41
Altman Z-Score -0.41
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 12.9%
Operating Profit Margin -1.4%
EBITDA Margin -15.1%
Net Profit Margin -24.1%
FCF Margin 0.8%
Adj. FCF Margin -1.0%
SBC / Revenue 1.8%
SBC Impact (per share) -225.0%
Returns
Return on Assets -25.6%
Return on Equity -99.2%
Return on Invested Capital -1.9%
Return on Capital Employed -1.9%
Return on Tangible Assets -69.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 8.7%
Revenue CAGR 5Y 17.2%
Revenue CAGR 10Y 27.0%
EPS CAGR 3Y -75.6%
EPS CAGR 5Y -58.9%
EPS CAGR 10Y -5.9%
FCF CAGR 3Y -191.9%
FCF CAGR 5Y -34.8%
FCF CAGR 10Y 57.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 30
EPS Growth Next 3Y 37.9%
Revenue Growth Next 3Y 25.2%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $0.06
EPS Growth Est (next Q) 20.0%
Revenue Est (next Q) $728.57M
Revenue Growth Est (next Q) 51.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7
Price Target Upside 89.7%
Cash Flow
Operating Cash Flow $53.33M
Free Cash Flow $16.95M
Adj. Free Cash Flow $-21.19M
FCF Per Share $0.15
OCF Per Share $0.47
OCF/S Ratio 2.5%
Income Statement
Revenue $2.1B
Gross Profit $270.83M
Operating Income $-28.68M
EBITDA $-317.04M
Net Income $-504.99M
EPS (Diluted) -$4.49
Revenue / Employee $499.29K
Profit / Employee $-120.24K
Employees 4,200
Add to Watchlist
Select watchlists to add or remove EVH